Rif1 S-acylation mediates DNA double-strand break repair at the inner nuclear membraneGabriele Fontana, Ulrich Rass|Nature Communications|2019Cited by 49
Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World StudyFrancesca Palandri, Massimo Breccia, Massimiliano Bonifacio et al.|Cancer|2024Cited by 10
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real‐world case seriesFrancesca Palandri, Mario Tiribelli, Filippo Branzanti et al.|British Journal of Haematology|2024Cited by 6